SKINConsumer Defensive · Household & Personal ProductsThe 9 Wall Street analysts covering Skinhealth Systems, Inc. hold a median 12-month price target of $13 — -21.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 94 of 100 as at 12 Nov 2026 — among the strongest tenth. The factors read stronger than the Street's target implies. That gap is the story on this page.
Consensus tells you what everyone already believes. The model scores Skinhealth Systems, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Accruals (95): Reported profit is backed by cash, and the company is not expanding recklessly.
Volatility (15): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on SKIN, reported as data — targets and ratings, the market's view beside the model's.
We don’t hold enough price history for this company yet.
The green dot is the last close — the median target sits −21.7% from it.
Of the 20 most recent actions, 3 moved their price target up and 2 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 9 Nov 2026 | TD Cowen | Maintains | Hold | $0.90 → $14 |
| 22 Oct 2026 | Canaccord Genuity | Maintains | Hold | — |
| 22 Oct 2026 | Canaccord Genuity | Maintains | Hold | $1.00 → $11 |
| 19 Oct 2026 | Jefferies | Maintains | Hold | — |
| 19 Oct 2026 | Jefferies | Maintains | Hold | $0.85 → $11 |
| 12 Aug 2026 | TD Cowen | Maintains | Hold | $1.00 → $0.90 |
| 12 Aug 2026 | TD Cowen | Maintains | Hold | — |
| 20 May 2026 | Roth Capital | Reiterates | Buy | $2.50 → $2.00 |
| 20 May 2026 | Roth Capital | Reiterates | Buy | — |
| 1 May 2026 | Canaccord Genuity | Maintains | Hold | — |
| 16 Mar 2026 | TD Cowen | Maintains | Hold | — |
| 13 Mar 2026 | Canaccord Genuity | Maintains | Hold | — |
| 21 Jan 2026 | TD Cowen | Maintains | Hold | — |
| 14 Jan 2026 | Jefferies | Assumes | Hold | $1.60 |
| 22 Sept 2025 | TD Cowen | Maintains | Hold | — |
| 19 Sept 2025 | Roth Capital | Initiates | Buy | — |
| 1 Aug 2025 | Stifel | Maintains | Hold | — |
| 5 May 2025 | Canaccord Genuity | Maintains | Hold | — |
| 13 Mar 2025 | Canaccord Genuity | Maintains | Hold | — |
| 13 Nov 2024 | Canaccord Genuity | Maintains | Hold | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
SKIN appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 99% of US stocks
Cheaper than 85% of US stocks
Cheaper than 45% of US stocks
Cheaper than 40% of US stocks
Higher than 25% of US stocks
Higher than 29% of US stocks
Higher than 81% of US stocks
Higher than 50% of US stocks
Higher than 22% of US stocks
Higher than 27% of US stocks
Higher than 49% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Skinhealth Systems, Inc. has a market value of $108.6M and an enterprise value of $260.9M.
Revenue in the twelve months to 30 June 2026: $290.0M. The latest quarter shrank 2.1% year on year.
Net income over the same four quarters: −$28.4M, a −9.8% net margin.
Diluted earnings per share, trailing twelve months: −$0.22.
Free cash flow in the twelve months to 30 June 2026: $16.6M.
Trailing P/E: −202.4×; forward P/E: 4.2× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
Skinhealth Systems, Inc. employs 613 people — $473K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Skinhealth Systems, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Zacks Investment Research highlights an examination of SkinHealth Systems Inc.’s international revenue trends and their potential impact on Wall Street predictions and the stock’s prospects.
Why it matters — International revenue trends may be relevant to investors assessing SKIN and the outlook reflected in Wall Street predictions.
SkinHealth Systems held its Q3 2026 earnings call on November 5, 2026, with CEO and President Pedro Malha and CFO and COO Michael Monahan participating. The excerpt lists analysts and provides no earnings results or business updates.
Why it matters — The excerpt confirms the call and its participants, but contains no financial or operational details for SKIN watchers to assess.
Beauty Health (NASDAQ: SKIN), referred to as SkinHealth Systems on its earnings call, reported a narrower revenue decline and higher adjusted earnings in Q3 2026. Growth in consumables helped offset weaker equipment sales.
Why it matters — The results highlight how consumables growth and equipment sales affected SKIN’s third-quarter performance.
SkinHealth Systems reported a third-quarter loss of $0.14 per share, compared with the Zacks Consensus Estimate of a $1.32 loss and a $1.80 loss per share a year earlier. The headline also says the company topped revenue estimates.
Why it matters — SKIN watchers may note the reported per-share loss was smaller than both the consensus estimate and the year-ago loss.
Zacks Investment Research highlights SkinHealth Systems Inc.’s (SKIN) Q3 results for the quarter ended September 2026, focusing on how key metrics compared with Wall Street estimates and year-ago values. The excerpt provides no specific results or comparisons.
Why it matters — A SKIN watcher may find the metric comparisons useful for assessing quarterly performance, though the excerpt does not disclose the figures.
The 9 Wall Street analysts covering Skinhealth Systems, Inc. have a median 12-month price target of $13, with estimates ranging from $10 to $24. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 9 analysts covering Skinhealth Systems, Inc., 1 rate it a Buy, 6 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks Skinhealth Systems, Inc. 94 out of 100 across roughly 4,600 US stocks as at 12 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 12 Nov 2026, Skinhealth Systems, Inc. ranks 94 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (95 of 100).
No one can know that. What the data says: the median 12-month target from 9 analysts implies -21.7% from the last close, and Ticker Nerd's factor model ranks Skinhealth Systems, Inc. 94 out of 100 as at 12 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Skinhealth Systems, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SKIN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $10 to $24 over the next 12 months.
SkinHealth Systems Inc. is a global medical aesthetics company that develops, manufactures, markets, and sells professional skincare technologies and related products.
The most recent item we track (Zacks Investment Research, 9 Nov 2026): "Investing in SkinHealth Systems Inc. (SKIN)? Don't Miss Assessing Its International Revenue Trends". Zacks Investment Research highlights an examination of SkinHealth Systems Inc.’s international revenue trends and their potential impact on Wall Street predictions and the stock’s prospects.
SkinHealth Systems Inc. is a global medical aesthetics company that develops, manufactures, markets, and sells professional skincare technologies and related products. Its portfolio centers on Hydrafacial, an integrated treatment platform combining specialized equipment, proprietary consumables, and provider-delivered skincare services. Complementary offerings include SkinStylus microneedling and HydraScalp with Keravive, which support procedures focused on skin renewal and scalp care. The company serves aesthetic providers and consumers through a worldwide network that connects professional treatments with branded products and clinical support. Its business model spans device technology, consumable products, treatment protocols, and provider enablement, positioning SkinHealth Systems Inc. within the medical aesthetics, skincare, and personal wellness markets. By combining in-office procedures with recurring product use, the company supports clinics, med spas, dermatology practices, and other providers seeking standardized aesthetic treatment experiences. SkinHealth Systems Inc. is headquartered in Long Beach, California, and operates across international markets.
CEO Mr. Pedro Malha · 613 employees · United States · https://www.skinhealthsystems.com